Prescribing of diabetes medications to people with type 2 diabetes and chronic kidney disease: a national cross-sectional study.

Jo-Anne E Manski-NankervisSharmala ThuraisingamJanet K SluggettGary KilovJohn FurlerDavid O'NealAlicia Jenkins

Published in: BMC family practice (2019)

Prescribing of non-insulin diabetes medications at doses inconsistent with current ADS guideline recommendations for dosing adjustments for people with renal impairment was common. Further research is needed to understand how general practitioners access, interpret and apply the ADS guidelines and the impact this may have on patient outcomes.

Keyphrases

type diabetes
glycemic control
chronic kidney disease
primary care
cardiovascular disease
clinical practice
end stage renal disease
adverse drug
quality improvement
insulin resistance
weight loss
peritoneal dialysis
metabolic syndrome
drug induced